Literature DB >> 30359984

Nonsteroidal Anti-Inflammatory Drug-Induced Colopathy in a Colorectal Cancer Screening Program.

Sanja Borozan1, Ljiljana Vuckovic2, Brigita Smolovic3.   

Abstract

OBJECTIVE: To present a case of colopathy related to the use of diclofenac in a patient with a positive immunochemical faecal occult blood test (iFOBT) and to discuss the influence of nonsteroidal anti-inflammatory drugs (NSAIDs) on iFOBT specificity. CLINICAL PRESENTATION AND INTERVENTION: A colonoscopy in a 56-year-old female presenting with a positive iFOBT revealed diaphragm-like strictures and ulcers in the right colon. While carrying out a detailed retrospective interview, she reported a chronic backache requiring long-term NSAID treatment.
CONCLUSION: No association has been established between chronic use of NSAID and a false-positive iFOBT. There is no need to stop NSAIDs before performing an iFOBT in a colorectal cancer screening program.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Colopathy; Colorectal cancer screening; Diaphragms; Immunochemical faecal occult blood test; Nonsteroidal anti-inflammatory drugs

Mesh:

Substances:

Year:  2018        PMID: 30359984      PMCID: PMC6545911          DOI: 10.1159/000494839

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  10 in total

1.  What is the role of iFOBT in screening for colorectal cancer?

Authors:  David F Ransohoff
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

2.  Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.

Authors:  Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Nicky Lieberman; Shmuel Klang; Yaron Niv
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

Review 3.  Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.

Authors:  Jeffrey K Lee; Elizabeth G Liles; Stephen Bent; Theodore R Levin; Douglas A Corley
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

4.  Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.

Authors:  Martin C S Wong; Jessica Y L Ching; Victor C W Chan; Thomas Y T Lam; Arthur K C Luk; Simon S M Ng; Joseph J Y Sung
Journal:  Gastrointest Endosc       Date:  2014-10-05       Impact factor: 9.427

5.  Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans.

Authors:  Charles J Kahi; Thomas F Imperiale
Journal:  Am J Med       Date:  2004-12-01       Impact factor: 4.965

6.  False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.

Authors:  Montse Garcia; Núria Milà; Gemma Binefa; Josep Maria Borràs; Josep Alfons Espinàs; Víctor Moreno
Journal:  J Med Screen       Date:  2012-05-31       Impact factor: 2.136

Review 7.  Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?

Authors:  D Adebayo; I Bjarnason
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

8.  Risk factors for false positive and for false negative test results in screening with fecal occult blood testing.

Authors:  Inge Stegeman; Thomas R de Wijkerslooth; Esther M Stoop; Monique van Leerdam; M van Ballegooijen; Roderik A Kraaijenhagen; Paul Fockens; Ernst J Kuipers; Evelien Dekker; Patrick M Bossuyt
Journal:  Int J Cancer       Date:  2013-06-25       Impact factor: 7.396

Review 9.  Diaphragmatic disease of the colon: systematic review.

Authors:  P C Munipalle; T Garud; D Light
Journal:  Colorectal Dis       Date:  2013-09       Impact factor: 3.788

10.  Right-Sided Diverticulosis and Disparities from Left-Sided Diverticulosis in the Vietnamese Population Living in Boston, Mass., USA: A Retrospective Cohort Study.

Authors:  Raman Mehrzad; Suprav Mishra; Garrey Faller; Babar Memon; Joseph Fiore
Journal:  Med Princ Pract       Date:  2015-04-22       Impact factor: 1.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.